Mentioned in ?
References in periodicals archive ?
9, 2015 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF), the leading pulmonary (PF) fibrosis information resource, today announced a record number of scientific poster presentations concerning idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases to be featured at the upcoming PFF Summit 2015: From Bench to Bedside, which will take place November 12-14 in Washington D.
The grouping of the two firms will produce a fully integrated, oncology-focused research and development company with a multi-phase clinical pipeline, platform technologies for the discovery of new, nucleic acid-based immunotherapies and other anti-cancer DNA/RNA therapies, and expertise from bench to bedside.
The students previously won more than $20,000 in cash prizes and grants through other student competitions at the university, including Bench to Bedside, a medical device competition; the Utah Entrepreneur Challenge, a statewide business plan competition; and the Entrepreneur Club milestone funding program.
With double the number of tracks this year, the Immunogenicity Summit 2013 presents technologies for safety and efficacy from bench to bedside.
These things take time to get from bench to bedside but patients can look at this with some optimism," Prof Megson added.
They and their colleagues were the first to translate transplant tolerance through mixed chimerism from bench to bedside and together, their work has been regarded as the first successful trial in humans of intentional solid organ tolerance induction.
The opening ceremony and keynote speaker are always inspirational, but the Bench to Bedside lecture is always the most exciting session for me," says Planning Team Member Terry Throckmorton, PhD, RN.
18-20 The 2009 Joanna Briggs International Convention, "Ripples to Revolution: From Bench to Bedside," in Adelaide, South Australia; visit www.
Two Midland universities are being awarded nearly pounds 20 million to develop the world-class medical research conducted at both institutions to improve patient care from bench to bedside.
The bench to bedside framework does not address the crucial problem of determining, in a reasonably precise and principled way, the level of acceptable risks of harm that can be imposed on patient-subjects in the course of clinical trials.
Together with our collaborator institutions, we will work toward moving translational research from bench to bedside to community.
To accelerate the advancement of stem cell biology from bench to bedside for treatment of cardiovascular disease, the National Institutes of Health (NIH) will host the scientific symposium Cardiovascular Regenerative Medicine at the NIH Natcher Conference Center in Bethesda, Maryland.